 |
|
Mayo Clinic researchers measuring C-reactive protein is early indicator of stiffened arteries
August 24, 2005May help identify heart disease in patients who have no symptoms
The Mayo Clinic research report appears online and in the August issue of the American Journal of Hypertension, http://www.sciencedirect.com/science/journal/08957061. The Mayo Clinic collaborative study with researchers from the University of Michigan looked at 214 men and women with an average age of 59, who had no history of heart attack or stroke. Results suggest that low grade inflammation is associated with arterial stiffness (hardening). This inflammation may be a potential mechanism through which C-reactive protein is related to heart attack and stroke, and why testing for C-reactive protein in a blood test may be an effective early warning test for asymptomatic, or presymptomatic heart disease.
Significance of Mayo Clinic Research
Researchers around the world agree that C-reactive protein is associated with increased risk of heart attack and stroke. But it remains controversial whether C-reactive protein is a risk factor that affects the function of blood vessels, or if it is simply a marker signifying the presence of disease.
In addition to taking into account the traditional risk factors for heart disease-such as male sex, presence of diabetes, high blood pressure, high cholesterol and smoking-the research team also measured C-reactive protein levels as well as three indicators of arterial stiffness. Stiffening of arteries indicates a loss of their elastic properties and predisposes to heart attack, stroke and congestive heart failure.
Says lead Mayo Clinic researcher Iftikhar Kullo, M.D., "The current inability to accurately predict cardiovascular events such as heart attack is a problem, and anything we can do to improve risk assessment is a public health priority. Our study provides a new insight into how low grade inflammation could be related to heart and stroke by its association with arterial stiffness. Thus suppression of inflammation may be a target of drug therapy to improve arterial health."
Mayo Clinic
Researchers around the world agree that C-reactive protein is associated with increased risk of heart attack and stroke. But it remains controversial whether C-reactive protein is a risk factor that affects the function of blood vessels, or if it is simply a marker signifying the presence of disease.
In addition to taking into account the traditional risk factors for heart disease-such as male sex, presence of diabetes, high blood pressure, high cholesterol and smoking-the research team also measured C-reactive protein levels as well as three indicators of arterial stiffness. Stiffening of arteries indicates a loss of their elastic properties and predisposes to heart attack, stroke and congestive heart failure.
Says lead Mayo Clinic researcher Iftikhar Kullo, M.D., "The current inability to accurately predict cardiovascular events such as heart attack is a problem, and anything we can do to improve risk assessment is a public health priority. Our study provides a new insight into how low grade inflammation could be related to heart and stroke by its association with arterial stiffness. Thus suppression of inflammation may be a target of drug therapy to improve arterial health."
Mayo Clinic
C-reactive Protein Current Events and C-reactive Protein News RSSPresence of gum disease may help dentists and physicians identify risk for cardiovascular disease
Individuals reporting a history of periodontal disease were more likely to have increased levels of inflammation, a risk factor for heart disease, compared to those who reported no history of periodontal disease.
Vitamin C lowers levels of heart disease biomarker, finds study, adds to debate of health benefits
A new study led by researchers at the University of California, Berkeley, adds to the evidence that vitamin C supplements can lower concentrations of C-reactive protein (CRP), a central biomarker of inflammation that has been shown to be a powerful predictor of heart disease and diabetes.
Researchers discover new risk factor for cardiovascular disease, and a way to control it
A team of international researchers - including scientists from the McGill University Health Centre (MUHC) and McGill University - have discovered that having high levels of particular protein puts patients at increased risk of developing cardiovascular disease.
Dark chocolate: Half a bar per week to keep at bay the risk of heart attack
Maybe gourmands are not jumping for joy. Probably they would have preferred bigger amounts to sup-port their passion. Though the news is still good for them: 6.7 grams of chocolate per day represent the ideal amount for a protective effect against inflammation and subsequent cardiovascular disease.
Heavy breathing -- an obscure link in asthma and obesity
There is a strong link between obesity and asthma and as the prevalence of both conditions has been increasing steadily, epidemiologists have speculated that there is an underlying condition that connects the two.
Low vitamin D levels associated with death from cardiovascular, all causes
Individuals with lower blood levels of vitamin D appear to have an increased risk of death overall and from cardiovascular causes, according to a report in the June 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Blood cholesterol levels predict risk of heart disease due to hormone therapy
A new analysis of a subgroup of participants in the Women's Health Initiative (WHI) hormone therapy clinical trials suggests that healthy, postmenopausal women whose blood cholesterol levels are normal or lower are not at increased, short-term risk for heart attack when taking hormone therapy.
Study finds it pays to be heart smart if considering hormone therapy
A research study has found that a simple blood test may indicate whether post-menopausal hormone therapies present an elevated risk of a heart attack.
OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival
An Oregon Health & Science University Cancer Institute researcher has identified a protein that is a strong indicator of survival for men with advanced prostate cancer. The C-reactive protein, also known as CRP, is a special type of protein produced by the liver that is elevated in the presence of inflammation.
New research shows no link between aromatase inhibitors and cardiovascular problems
New evidence has emerged that, contrary to some current fears, aromatase inhibitors (AIs) are not associated with an increased risk of heart problems in women who take them to prevent their breast cancer recurring.
More C-reactive Protein Current Events and C-reactive Protein News Articles
 | C-Reactive Protein : Everthing You Need to Know About It and Why It's More Important Than Cholesterol to Your Health by Scott J. Deron The first comprehensive resource on CRP--a powerful new way to assess heart attack risk Half of all heart attacks and strokes occur in people with normal cholesterol levels--a phenomenon that has long baffled doctors. C-Reactive Protein, or CRP, is a newly discovered measure of inflammation in the body that some researchers believe is twice as important as cholesterol in predicting one's... |
 | C-Reactive Protein and Cardiovascular Disease by Paul M. Ridker, Nader Rifai "C-Reactive Protein and Cardiovascular Disease", edited by Drs Paul Ridker and Nader Rifai from the Harvard Medical School, is the first comprehensive review of inflammation, heart disease, and the clinical application of high sensitivity C-reactive protein (hsCRP) to daily practice. Multiple studies now show hsCRP to be a powerful predictor of future cardiovascular events even when... |
| C-reactive protein and the plasma protein response to tissue injury (Annals of the New York Academy of Sciences) | |
 | How To Determine Whether You Should be Tested for C-Reactive Protein by Quick Easy Guides C-Reactive Protein is a protein found in the blood. C-Reactive Protein is produced by the body during inflammation, which is the body's natural response to many conditions ranging...Written by experts in the field, Quick Easy Guides share little-known trade secrets and helpful hints to get you moving in the right direction.Quick Easy Guides gives you books you can judge by the cover. Our books... |
| Exercise may lower level of C-reactive protein: anti-inflammatory effect. (Clinical Rounds).: An article from: Family Practice News by Bruce Jancin This digital document is an article from Family Practice News, published by International Medical News Group on June 1, 2003. The length of the article is 435 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| C-Reactive Protein and the Plasma Protein Response to Tissue Injury. by Irving, John E. Volanakis, Henry Gewurz, editors. Kushner | |
| C-reactive protein levels may predict cardiovascular risk. (Patients on Statins).: An article from: Family Practice News by Patrice G.W. Norton This digital document is an article from Family Practice News, published by International Medical News Group on March 1, 2003. The length of the article is 1422 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Low magnesium intake linked with elevated CRP levels.(Cardiovascular Medicine)(C-reactive protein): An article from: Internal Medicine News by Diana Mahoney This digital document is an article from Internal Medicine News, published by International Medical News Group on January 1, 2005. The length of the article is 682 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web... | |
| Depression trumps high CRP level in cardiac risk.(Psychosomatic Medicine)(C-reactive protein): An article from: Clinical Psychiatry News by Miriam E. Tucker This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on April 1, 2004. The length of the article is 883 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web... | |
| C-Reactive Protein Guide's Antibiotics for URIs.(upper respiratory infection): An article from: Internal Medicine News by Bruce Jancin This digital document is an article from Internal Medicine News, published by International Medical News Group on July 1, 2001. The length of the article is 370 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... |
| © 2008 BrightSurf.com |